Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Dutch Bros Inc a un objectif de cours consensuel de $77.9 basé sur les évaluations de 20 analystes. Le plus élevé est $90, publié par Wedbush le mars 31, 2025. Le plus bas est $63, publié par Piper Sandler le novembre 6, 2025. Les 3 évaluations d’analystes les plus récentes ont été publiées par Piper Sandler, RBC Capital et Barclays le novembre 6, 2025, respectivement. Avec un objectif de cours moyen de $70 entre Piper Sandler, RBC Capital et Barclays, il existe une variation implicite de 33.85% upside pour Dutch Bros Inc selon ces dernières évaluations d’analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/06/2025 | 20.47% | Piper Sandler | $73 → $63 | Maintains | Neutral | |||
11/06/2025 | 43.41% | RBC Capital | $85 → $75 | Maintains | Outperform | |||
11/06/2025 | 37.68% | Barclays | $65 → $72 | Maintains | Overweight | |||
10/31/2025 | 43.41% | Stifel | $82 → $75 | Maintains | Buy | |||
10/28/2025 | 33.85% | Mizuho | → $70 | Initiates | → Outperform | |||
10/22/2025 | 64.45% | Morgan Stanley | $84 → $86 | Maintains | Overweight | |||
10/22/2025 | 24.29% | Barclays | $92 → $65 | Maintains | Overweight | |||
10/16/2025 | 33.85% | Wells Fargo | $80 → $70 | Maintains | Overweight | |||
09/30/2025 | 37.68% | Goldman Sachs | $81 → $72 | Maintains | Neutral | |||
09/24/2025 | 62.53% | RBC Capital | $85 → $85 | Reiterates | Outperform → Outperform | |||
08/28/2025 | 62.53% | UBS | $80 → $85 | Maintains | Buy | |||
08/19/2025 | 64.45% | TD Cowen | $86 → $86 | Reiterates | Buy → Buy | |||
08/07/2025 | 64.45% | TD Cowen | $86 → $86 | Reiterates | Buy → Buy | |||
08/07/2025 | 60.62% | Morgan Stanley | $80 → $84 | Maintains | Overweight | |||
08/07/2025 | 62.53% | RBC Capital | $83 → $85 | Maintains | Outperform | |||
08/07/2025 | 45.32% | Guggenheim | $72 → $76 | Maintains | Buy | |||
08/07/2025 | 75.92% | Barclays | $84 → $92 | Maintains | Overweight | |||
08/07/2025 | 60.62% | B of A Securities | $80 → $84 | Maintains | Overweight | |||
07/17/2025 | 60.62% | Barclays | $82 → $84 | Maintains | Overweight | |||
06/30/2025 | 52.97% | CICC | → $80 | Initiates | → Outperform | |||
06/26/2025 | 43.41% | Goldman Sachs | → $75 | Initiates | → Neutral | |||
05/14/2025 | 58.71% | RBC Capital | → $83 | Initiates | → Outperform | |||
05/08/2025 | 56.8% | Barclays | $76 → $82 | Maintains | Overweight | |||
05/08/2025 | 20.47% | Piper Sandler | $70 → $63 | Maintains | Neutral | |||
05/08/2025 | 56.8% | Stifel | $85 → $82 | Maintains | Buy | |||
05/08/2025 | 37.68% | Baird | $66 → $72 | Maintains | Outperform | |||
05/08/2025 | 49.15% | TD Securities | $78 → $78 | Reiterates | Buy → Buy | |||
05/05/2025 | 52.97% | UBS | $90 → $80 | Maintains | Buy | |||
04/22/2025 | 45.32% | Barclays | $94 → $76 | Maintains | Overweight | |||
04/07/2025 | 26.2% | Baird | $80 → $66 | Maintains | Outperform | |||
03/31/2025 | 37.68% | Guggenheim | $54 → $72 | Maintains | Buy | |||
03/31/2025 | 72.09% | Wedbush | $90 → $90 | Reiterates | Outperform → Outperform | |||
03/28/2025 | 70.18% | TD Securities | $89 → $89 | Reiterates | Buy → Buy | |||
03/26/2025 | 52.97% | Wells Fargo | → $80 | Initiates | → Overweight | |||
03/24/2025 | 56.8% | Morgan Stanley | → $82 | Initiates | → Overweight | |||
02/28/2025 | 62.53% | Stifel | $74 → $85 | Maintains | Buy | |||
02/13/2025 | 52.97% | JP Morgan | $58 → $80 | Maintains | Overweight | |||
02/13/2025 | 33.85% | Piper Sandler | $51 → $70 | Maintains | Neutral | |||
02/13/2025 | 41.5% | Stifel | $62 → $74 | Maintains | Buy | |||
02/13/2025 | 72.09% | UBS | $67 → $90 | Maintains | Buy | |||
02/13/2025 | 81.65% | Baird | $70 → $95 | Maintains | Outperform | |||
02/13/2025 | 91.22% | Wedbush | $65 → $100 | Maintains | Outperform | |||
02/13/2025 | 70.18% | TD Securities | $65 → $89 | Maintains | Buy | |||
01/27/2025 | 37.68% | B of A Securities | $61 → $72 | Maintains | Buy | |||
01/15/2025 | 31.94% | Jefferies | $60 → $69 | Maintains | Buy | |||
01/13/2025 | 28.11% | UBS | $65 → $67 | Maintains | Buy | |||
01/10/2025 | 18.55% | Stifel | $53 → $62 | Maintains | Buy | |||
01/07/2025 | 33.85% | Barclays | $38 → $70 | Upgrade | Equal-Weight → Overweight | |||
01/06/2025 | 33.85% | Baird | $60 → $70 | Upgrade | Neutral → Outperform | |||
12/19/2024 | 10.91% | JP Morgan | $48 → $58 | Maintains | Overweight | |||
12/16/2024 | 14.73% | Jefferies | $45 → $60 | Maintains | Buy | |||
12/06/2024 | 24.29% | UBS | $44 → $65 | Maintains | Buy | |||
11/14/2024 | 1.34% | Stifel | $42 → $53 | Maintains | Buy | |||
11/11/2024 | -2.48% | Piper Sandler | $36 → $51 | Maintains | Neutral | |||
11/08/2024 | -27.34% | Barclays | $31 → $38 | Maintains | Equal-Weight | |||
11/07/2024 | -2.48% | B of A Securities | $49 → $51 | Maintains | Buy | |||
11/07/2024 | -8.22% | JP Morgan | $44 → $48 | Maintains | Overweight | |||
11/07/2024 | -12.04% | Baird | $37 → $46 | Maintains | Neutral | |||
11/07/2024 | -15.87% | UBS | $39 → $44 | Maintains | Buy | |||
11/07/2024 | 5.17% | Wedbush | $45 → $55 | Maintains | Outperform | |||
11/07/2024 | 1.34% | TD Cowen | $47 → $53 | Maintains | Buy | |||
10/14/2024 | -13.95% | Wedbush | $45 → $45 | Reiterates | Outperform → Outperform | |||
09/12/2024 | -10.13% | TD Cowen | $47 → $47 | Reiterates | Buy → Buy | |||
08/19/2024 | -31.16% | Piper Sandler | $41 → $36 | Downgrade | Overweight → Neutral | |||
08/15/2024 | -25.43% | UBS | → $39 | Upgrade | Neutral → Buy | |||
08/09/2024 | -40.72% | Barclays | $35 → $31 | Maintains | Equal-Weight | |||
08/08/2024 | -27.34% | Stifel | $40 → $38 | Maintains | Buy | |||
08/08/2024 | -13.95% | Wedbush | $45 → $45 | Reiterates | Outperform → Outperform | |||
08/08/2024 | -29.25% | Baird | $42 → $37 | Maintains | Neutral | |||
08/08/2024 | -10.13% | TD Cowen | $50 → $47 | Maintains | Buy | |||
07/11/2024 | -31.16% | Guggenheim | $30 → $36 | Maintains | Neutral | |||
07/03/2024 | -19.69% | Baird | $33 → $42 | Maintains | Neutral | |||
06/18/2024 | -4.39% | TD Cowen | $50 → $50 | Reiterates | Buy → Buy | |||
06/13/2024 | -4.39% | TD Cowen | $46 → $50 | Maintains | Buy | |||
06/10/2024 | -6.3% | B of A Securities | $44 → $49 | Maintains | Buy | |||
06/05/2024 | -12.04% | TD Cowen | $46 → $46 | Reiterates | Buy → Buy | |||
06/03/2024 | -15.87% | JP Morgan | $40 → $44 | Maintains | Overweight | |||
05/16/2024 | -13.95% | Wedbush | $39 → $45 | Maintains | Outperform | |||
05/10/2024 | -12.04% | TD Cowen | $33 → $46 | Upgrade | Hold → Buy | |||
05/08/2024 | -33.07% | Barclays | $30 → $35 | Maintains | Equal-Weight | |||
05/08/2024 | -25.43% | Wedbush | $37 → $39 | Maintains | Outperform | |||
04/26/2024 | -36.9% | TD Cowen | $33 → $33 | Reiterates | Hold → Hold | |||
04/12/2024 | -36.9% | TD Cowen | $33 → $33 | Reiterates | Hold → Hold | |||
04/11/2024 | -36.9% | TD Cowen | $33 → $33 | Reiterates | Hold → Hold | |||
04/10/2024 | -29.25% | Wedbush | $37 → $37 | Reiterates | Outperform → Outperform | |||
04/10/2024 | -36.9% | TD Cowen | $33 → $33 | Reiterates | Hold → Hold | |||
04/05/2024 | -42.64% | Guggenheim | $30 → $30 | Reiterates | Neutral → Neutral | |||
04/03/2024 | -29.25% | Wedbush | $37 → $37 | Reiterates | Outperform → Outperform | |||
04/03/2024 | -23.51% | Stifel | $40 → $40 | Maintains | Buy | |||
03/19/2024 | -23.51% | JP Morgan | $34 → $40 | Maintains | Overweight | |||
03/04/2024 | -29.25% | Piper Sandler | $32 → $37 | Upgrade | Neutral → Overweight | |||
02/22/2024 | -36.9% | TD Cowen | $33 → $33 | Reiterates | Market Perform → Market Perform | |||
02/22/2024 | -29.25% | Wedbush | $37 → $37 | Reiterates | Outperform → Outperform | |||
02/22/2024 | -42.64% | Barclays | $31 → $30 | Maintains | Equal-Weight | |||
01/16/2024 | -33.07% | Stifel | $32 → $35 | Upgrade | Hold → Buy | |||
01/03/2024 | -40.72% | Barclays | $28 → $31 | Maintains | Equal-Weight | |||
12/21/2023 | -29.25% | Wedbush | $35 → $37 | Maintains | Outperform | |||
11/20/2023 | -33.07% | JP Morgan | $30 → $35 | Upgrade | Neutral → Overweight | |||
11/08/2023 | -33.07% | Wedbush | $31 → $35 | Maintains | Outperform | |||
11/03/2023 | -40.72% | Wedbush | $37 → $31 | Maintains | Outperform |
Le dernier objectif de prix pour Dutch Bros (NYSE:BROS) a été rapporté par Piper Sandler le novembre 6, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $63.00 s'attendant à ce que BROS se rise dans les 12 prochains mois (un possible changement de 16.75% upside). 52 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Dutch Bros (NYSE:BROS) a été fournie par Piper Sandler, et Dutch Bros maintenu leur note neutral.
La dernière amélioration pour Dutch Bros Inc a eu lieu le janvier 7, 2025 lorsque Barclays a augmenté leur objectif de prix à $70. Barclays avait précédemment an equal-weight pour Dutch Bros Inc.
La dernière réduction pour Dutch Bros Inc a eu lieu le août 19, 2024 lorsque Piper Sandler a changé leur objectif de prix de $41 à $36 pour Dutch Bros Inc.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Dutch Bros, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Dutch Bros a été déposée le novembre 6, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 6, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Dutch Bros (BROS) était un maintenu avec un objectif de prix de $73.00 à $63.00. Le prix actuel de Dutch Bros (BROS) est de $53.96, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.